Molecular Medicine - Canada News Beep

Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial

August 6, 2026

This study of psilocybin assisted-therapy for TRD—to our knowledge, the first RCT in this population to assess feasibility…

HHealthcare

Divergent impacts of explainable AI for dermatological diagnosis on clinicians versus lay people

August 5, 2026

Study design We designed two complementary large-scale experiments to evaluate human−AI collaborative diagnostic performance across expertise levels (Fig.…

SScience

Learning from routine health system data builds better neuroimaging AI models

July 31, 2026

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This…

HHealthcare

Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trial

July 29, 2026

Trial design and oversight The STIMULATE-ICP trial aimed to investigate the efficacy of an enhanced ICP for LC,…

HHealthcare

Genomas Brasil program: building precision public health within Brazil’s Unified Health System

July 21, 2026

Patel, H. N. et al. J. Pharm. Bioallied Sci. 17, S1101–S3 (2025). Article PubMed PubMed Central Google Scholar …

HHealthcare

Health system learning enables generalist neuroimaging models

July 10, 2026

Health system learning We define ‘health system learning’ as learning directly from uncurated data generated during routine clinical…

HHealthcare

Generative AI-enabled clinical decision support system in primary care: a pragmatic, cluster-randomized trial

June 26, 2026

Design We conducted a pragmatic, multicenter, parallel-group cluster-randomized controlled trial across a network of 16 primary care facilities…

HHealthcare

Evaluating the robustness and readiness of large frontier models in health AI applications

June 26, 2026

Singhal, K. et al. Large language models encode clinical knowledge. Nature 620, 172–180 (2023). Article CAS PubMed PubMed…

MMedication

Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial

June 12, 2026

Trial details EMBRAZE was a randomized, double-blind, placebo-controlled, phase 2 trial (NCT06445075) conducted at seven sites in the…

SScience

Towards mRNA therapeutics 2.0 | Nature Reviews Drug Discovery

June 4, 2026

Kallen, K.-J. et al. A novel, disruptive vaccination technology: self-adjuvanted RNActive® vaccines. Hum. Vaccin. Immunother. 9, 2263–2276 (2013). Article …

HHealthcare

Advancing conversational diagnostic AI with multimodal reasoning

May 14, 2026

This work advances the diagnostic capabilities of the multimodal AMIE system4,5 by integrating multimodal perception, enabling it to…

HHealthcare

AI framework for multidisease detection via retinal imaging

April 29, 2026

Study population For the model training, we used CFPs from the UKB and three hospital-based centers in China…